What is NDC 0409-1754?

0409-1754 is the product NDC for Magnesium Sulfate, Magnesium sulfate heptahydrate 500 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Magnesium sulfate heptahydrate.

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Magnesium Sulfate?

29 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Magnesium Sulfate NDC 0409-1754 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-1754Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-1754Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-1754-10	0040917541000409175410	10 CARTON in 1 PACKAGE (0409-1754-10) / 1 SYRINGE, PLASTIC in 1 CARTON / 10 mL in 1 SYRINGE, PLASTIC (0409-1754-15)Marketed from Nov 28, 2006

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Magnesium Sulfate
Generic name (nonproprietary): magnesium sulfate
Active ingredients: Magnesium sulfate heptahydrate — 500 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075151
Marketing start: Nov 28, 2006
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0409-1754_785d7821-eace-4e0b-8d45-5200ab4850f3SPL ID 785d7821-eace-4e0b-8d45-5200ab4850f3SPL set ID d4b5863a-efb9-4551-a9ad-2b06e8666d87RxCUI 829762UNII SK47B8698T
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409175410 followed by a unit qualifier and the quantity

Package 00409-1754-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. In such cases, the serum magnesium (Mg ++ ) level is usually below the lower limit of normal (1.5 to 2.5 mEq/liter) and the serum calcium (Ca ++ ) level is normal (4.3 to 5.3 mEq/liter) or elevated. In total parenteral nutrition (TPN), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. Magnesium Sulfate Injection, USP is also indicated for the prevention and control of seizures (conv…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-1754

What is NDC 0409-1754?: 0409-1754 is the product NDC for Magnesium Sulfate, Magnesium sulfate heptahydrate 500 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Magnesium Sulfate.
What is the active ingredient?: Magnesium sulfate heptahydrate.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Magnesium Sulfate?: 29 other product NDCs are listed under this name. See all Magnesium Sulfate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Magnesium Sulfate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 3 g/100mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	0338-6353	00338-6353-40
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	REMEDYREPACK INC.	70518-4375	70518-4375-0070518-4375-02
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Camber Pharmaceuticals, Inc.	31722-394	31722-0394-3231722-0394-3331722-0394-34+1 more
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7381	71872-7381-01
Magnesium Sulfatemagnesium sulfate in water for	Magnesium sulfate heptahydrate 40 mg/mL	InjectionIntravenous	Amneal Pharmaceuticals LLC	70121-1719	70121-1719-0270121-1719-09
Magnesium Sulfatemagnesium sulfate in water for	Magnesium sulfate heptahydrate 40 mg/mL	InjectionIntravenous	Amneal Pharmaceuticals LLC	70121-1720	70121-1720-0370121-1720-09
Magnesium Sulfate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9904	00404-9904-02
Magnesium Sulfate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9902	00404-9902-20
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9903	00404-9903-10
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 40 mg/mL	Injection, SolutionIntravenous	Sun Pharmaceutical Industries, Inc.	47335-992	47335-0992-0147335-0992-02

All 30 Magnesium Sulfate NDCs

Other NDCs under ANDA 075151

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075151
Product	Strength	Form · route	Labeler	Product NDC
50% Magnesium Sulfate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	HF Acquisition Co. LLC, DBA Health First	51662-1235
Magnesium Sulfatemagnesium sulfate heptahydrate	Magnesium sulfate heptahydrate 500 mg/mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9903